ZA848375B - Medicament formulation - Google Patents

Medicament formulation

Info

Publication number
ZA848375B
ZA848375B ZA848375A ZA848375A ZA848375B ZA 848375 B ZA848375 B ZA 848375B ZA 848375 A ZA848375 A ZA 848375A ZA 848375 A ZA848375 A ZA 848375A ZA 848375 B ZA848375 B ZA 848375B
Authority
ZA
South Africa
Prior art keywords
medicament formulation
medicament
formulation
Prior art date
Application number
ZA848375A
Other languages
English (en)
Inventor
Peter Serno
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA848375B publication Critical patent/ZA848375B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA848375A 1983-10-28 1984-10-26 Medicament formulation ZA848375B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833339236 DE3339236A1 (de) 1983-10-28 1983-10-28 Arzneimittelzubereitung

Publications (1)

Publication Number Publication Date
ZA848375B true ZA848375B (en) 1985-06-26

Family

ID=6213011

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA848375A ZA848375B (en) 1983-10-28 1984-10-26 Medicament formulation

Country Status (14)

Country Link
US (1) US4711902A (xx)
EP (1) EP0143305A1 (xx)
JP (1) JPS60115517A (xx)
KR (1) KR850002953A (xx)
AU (1) AU3358784A (xx)
DE (1) DE3339236A1 (xx)
DK (1) DK510384A (xx)
ES (1) ES8604419A1 (xx)
FI (1) FI844199L (xx)
GR (1) GR80788B (xx)
HU (1) HU193908B (xx)
IL (1) IL73318A (xx)
NO (1) NO844144L (xx)
ZA (1) ZA848375B (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE3624624A1 (de) * 1986-07-18 1988-01-28 Asche Ag Xylometazolinhaltige pharmazeutische praeparate
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk １−〔２−（２，４−ジクロロフエニル）−３−メチル−１−ペンテニル〕−１ｈ−イミダゾ−ルを含有する水中油型脂肪乳剤
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung
FR2609714A1 (fr) * 1987-01-15 1988-07-22 Sanofi Sa Compositions liquides stables a base de derives antifongiques imidazoles
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
CA1326995C (en) * 1988-01-29 1994-02-15 Kozo Kurihara Cyclosporin compositions
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
DE68903930T2 (de) * 1988-11-23 1993-05-19 Abbott Lab Lipidemulsion zur behandlung von aids.
BE1003647A5 (fr) * 1989-02-28 1992-05-12 Syntex Inc Composition pharmaceutique de nicardipine pour administration parenterale.
JP2732918B2 (ja) * 1989-10-31 1998-03-30 ライオン株式会社 口腔清浄剤組成物
JP3074731B2 (ja) * 1989-12-01 2000-08-07 日本新薬株式会社 脂肪乳剤
WO1991007964A1 (en) * 1989-12-01 1991-06-13 Nippon Shinyaku Co., Ltd. Fat emulsion
TW211015B (xx) * 1990-01-11 1993-08-11 Nippon Shinyaku Co Ltd
EP0556392A4 (en) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING A FATTY EMULSION.
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
ATE183099T1 (de) * 1991-04-19 1999-08-15 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
SE9303744D0 (sv) * 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
US7205279B2 (en) * 1995-10-25 2007-04-17 Novartis Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
DK1105096T3 (da) 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
US8460693B2 (en) * 2001-11-08 2013-06-11 Atrium Medical Corporation Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent
KR100848755B1 (ko) * 2002-01-02 2008-07-25 주식회사 두산 포스파티딜세린 함유 액상 조성물 및 그 제조방법
ATE522498T1 (de) * 2002-01-25 2011-09-15 Theravance Inc Sedative hypnotisch wirkende verbindungen mit kurzer wirkungsdauer zur anaesthesie und sedierung
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
ATE444734T1 (de) * 2003-07-23 2009-10-15 Theravance Inc Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
BRPI0501120A (pt) * 2005-02-18 2006-10-03 Henry Jun Suzuki composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
BRPI0709617A2 (pt) * 2006-04-18 2011-07-19 Ekr Therapeutics Inc composição farmacêutica, e, métodos para tratar elevações agudas de pressão sangüìnea em um indivìduo humano, para induzir a hipotensão em um indivìduo humano, e para produzir uma composição farmacêutica para administração intravenosa
US9416065B2 (en) * 2007-02-12 2016-08-16 Archer Daniels Midland Company Adjuvants and methods of using them
DE102007058785B3 (de) * 2007-12-06 2009-08-20 Hewitech Gmbh & Co. Kg Zusammensteckbare Entwässerungs- und/oder Drainagevorrichtung
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
CN102917687A (zh) * 2010-05-13 2013-02-06 阿斯利康(瑞典)有限公司 镇静催眠剂的可注射乳液
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
CN104105472A (zh) 2011-12-20 2014-10-15 维奥姆生物科学有限公司 用于治疗真菌感染的局部油组合物
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
WO2014167554A2 (en) * 2013-04-12 2014-10-16 Vyome Biosciences Pvt. Ltd. Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE592881C (de) * 1932-03-27 1934-02-16 Carl Weill Dr Verfahren zur Herstellung haltbarer, fuer Injektionszwecke geeigneter Emulsionen vonin Wasser unloeslichen oder schwer loeslichen Arzneimitteln
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2837477A1 (de) * 1978-08-28 1980-03-13 Bayer Ag Sila-substituierte 1,4-dihydropyridin- derivate
DE2935573A1 (de) * 1979-09-03 1981-03-19 Lepharm- Pharmazeutische Entwicklungs- und Vertriebsgesellschaft GmbH, 5000 Köln Infusionsloesungen mit mono- und diglyceriden von fettsaeuren
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
ES8604419A1 (es) 1986-02-01
EP0143305A1 (de) 1985-06-05
AU3358784A (en) 1985-05-02
DE3339236A1 (de) 1985-05-09
ES537022A0 (es) 1986-02-01
GR80788B (en) 1985-02-20
KR850002953A (ko) 1985-05-28
IL73318A0 (en) 1985-01-31
FI844199A0 (fi) 1984-10-25
FI844199L (fi) 1985-04-29
US4711902A (en) 1987-12-08
IL73318A (en) 1988-06-30
NO844144L (no) 1985-04-29
DK510384A (da) 1985-04-29
JPS60115517A (ja) 1985-06-22
HUT36703A (en) 1985-10-28
DK510384D0 (da) 1984-10-25
HU193908B (en) 1987-12-28

Similar Documents

Publication Publication Date Title
ZA848375B (en) Medicament formulation
GB8325529D0 (en) Medicinal forms
GB8414688D0 (en) Pharmaceutical preparation
EP0138029A3 (en) Pharmaceutical composition
DE3264782D1 (en) Medicinal formulation
GB8403572D0 (en) Pharmaceutical preparation
GB8413576D0 (en) Pharmaceutical preparation
GB8323624D0 (en) Medicinal compositions
GB8410363D0 (en) Pharmaceutical preparation
GB8422453D0 (en) Pharmaceutical formulation
DE3466477D1 (en) Pharmaceutical formulations
GB8429340D0 (en) Medicaments
GB8308414D0 (en) Pharmaceutical composition
GB8415067D0 (en) Medicine
GB8308097D0 (en) Pharmaceutical formulation
GB8326645D0 (en) Pharmaceutical formulation
GB8301368D0 (en) Pharmaceutical formulation
GB8329594D0 (en) Pharmaceutical formulation
GB8304454D0 (en) Pharmaceutical formulation
GB8316135D0 (en) Formulation
GB2162746B (en) Antiacidotic medicinal agent
GB8308313D0 (en) Formulation
GB8326646D0 (en) Formulation
IL69414A0 (en) Cosmetic-pharmaceutical formulation
GB8321801D0 (en) Pharmaceutical use